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T cells, like other cells of the blood system, are 
derived from pluripotent hematopoietic stem 
cells (HSCs). The major site of T cell develop-
ment is the thymus. Thus, descendants of HSCs 
migrate to the thymus, where they undergo a 
program of maturation, proliferation, and dif-
ferentiation. They pass through a CD4−CD8− 
double-negative (DN) developmental stage, 
followed by a CD4+CD8+ double-positive (DP) 
stage, before undergoing positive or negative 
selection to generate single-positive (SP) CD4+ 
and CD8+ T cells that migrate to the peri-
phery. The CD4−CD8− DN cells represent 
the most immature thymic subset that can be 
further subdivided into four developmental 
stages (DN1–4), based on their diff erential ex-
pression of CD44 and CD25, maturing from 
the CD44+CD25− (DN1) to the CD44+CD25+ 
(DN2) to the CD44−CD25+ (DN3) to the 
CD44−CD25− (DN4) stages (1–3). Many dif-
ferent signaling pathways have been shown to 
be involved in T lymphocyte development. 
One of these pathways is the Notch cascade, 
which has received a lot of attention in recent 
years because of its involvement in T lineage 
commitment, T cell maturation, and peripheral 
T cell function (4, 5). Notch proteins compose 
a family of four transmembrane receptors that 
infl uence cell fate decisions and diff erentiation 
processes in many diff erent organisms (6). 
Notch signaling is triggered upon binding of 
ligands of the Jagged and Delta family. This 
leads to a cascade of proteolytic cleavages that 
release the intracellular cytoplasmic domain of 
Notch receptors, which subsequently trans-
locates to the nucleus, where it binds to the 
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capacity to induce and support T cell development.
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RBP-J transcription factor and thereby activates  transcription. 
Notch signaling itself can be regulated by several  modulators, 
such as the family of Fringe proteins, which are glycosyl 
transferases that add N-acetylglucosamine to certain  epidermal 
growth factor–like repeats of Notch receptors, promoting 
Notch  signaling in response to Delta ligands and inhibiting 
Jagged-mediated Notch signaling (7).
The best-established role for Notch signaling in the 
 hematopoietic system is the essential function of Notch1 
(N1) in T cell fate specifi cation. Conditional inactivation of 
the N1 (8, 9) or RBP-J (10) genes in adult BM progenitors 
results in B cell development within the thymus at the ex-
pense of T cell lineage commitment, suggesting that N1/
RBP-J–mediated signaling is important to induce T cell de-
velopment and to simultaneously block B cell development. 
Although multiple Notch receptors such as N1, N2, and 
N3—as well as the ligands Jagged1, Jagged2, Delta1 (DL1), 
and DL4—are expressed on thymocytes and/or thymic epi-
thelium (11–18), T lineage commitment appears to be medi-
ated via the N1 receptor in a nonredundant manner. This 
is consistent with the fi nding that conditional inactivation 
of the N2 gene does not aff ect T cell development but is 
 instead necessary for marginal zone B cell (MZB cell) speci-
fi cation (19). Moreover, N3 gene–targeted mice do not ex-
hibit any hematopoietic phenotype (20). Further support 
for the essential role of Notch signaling in T cell lineage 
commitment is derived from gain-of-function studies, as 
overexpression of a constitutively active form of N1 (21, 22) 
or DL4 (13, 23, 24) induces ectopic T cell development 
in the BM and simultaneously blocks B cell development. 
Thus, these reciprocal loss- and gain-of-function studies 
 indicate that N1 signaling is necessary and suffi  cient for T cell 
lineage commitment.
An additional nonredundant function of N1 during thy-
mocyte maturation was revealed by conditional inactivation 
of the N1 gene in immature thymocytes. N1 defi ciency in 
DN thymocytes leads to a partial block of αβ T cell develop-
ment at the pre-TCR checkpoint because of defective V to 
DJβ rearrangement (25). Although N1 seems to be a key 
player during T lineage commitment and T cell maturation, 
several issues are still controversial or unknown. For example, 
the expression of multiple Notch ligands on thymic epithelial 
cells leads to the question of which ligand triggers the physio-
logical N1 signal for T lineage commitment and/or maturation. 
Figure 1. N2 signaling is suffi cient to induce T lineage commit-
ment in vitro but not in vivo. (A) Mixed BM chimeric mice were 
analyzed 8 wk after reconstitution with a 1:2 mixture of WT (CD45.1+) 
and Ctrl (N1lox/lox), N1−/−, N2−/−, or N1N2−/− (CD45.2+) BM-derived 
populations. Representative FACS analysis of thymocytes stained with 
anti-CD117, -CD44, and -CD25 antibodies after gating on donor 
(CD45.2+)-derived lineage-negative cells (top). Representative FACS 
analysis of thymocytes stained with anti-B220 and -CD19 antibodies 
after gating on donor (CD45.2+)-derived lineage-negative cells (bottom). 
Representative FACS profi les are derived from experiments in which fi ve 
mice of each genotype were analyzed. (B) BM KLS cells were sorted from 
Ctrl, N1−/−, N2−/−, and N1N2−/− mice and cultured on OP9-DL1 cells for 
10 d (top) and 18 d (bottom). Cells from these cultures were analyzed 
for the expression of CD44 and CD25 (top) and for the presence of 
B220+CD19+ B cells (bottom). Representative FACS profi les are derived 
from four individual experiments. (C) Deletion PCR analysis for the N1 
gene was performed on genomic DNA from sorted CD25− (corresponding 
to DN1) and CD25+ (corresponding to DN2/DN3) cells derived from N1−/− 
and Ctrl animals cultured for 10 d on OP9-DL1. (D) Semiquantitative 
RT-PCR for the expression of N1, N2, and tubulin was performed on 
sorted BM KLS cells. Three serial dilutions (threefold) of template RNA 
are shown for the indicated genes.
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Ligands of the Jagged family (Jagged1 and Jagged2) can be 
excluded as being essential during these processes, because 
conditional inactivation of Jagged1 (26) does not perturb he-
matopoiesis and Jagged2-defi cient mice show only a minor 
decrease in γδ T cells, whereas αβ T cell development ap-
pears normal (27). Thus, members of the Delta-like family 
seem to be the crucial ligands, because expression of DL1 or 
DL4 on stromal cells can induce T cell development of 
 human or mouse hematopoietic progenitors (28–30). Inter-
estingly, conditional inactivation of the DL1 gene in hemato-
poietic cells leads to the loss of MZB cells, indicating that DL1 
signals via N2 to specify this subclass of splenic B cells (30). 
Surprisingly, loss of DL1, even in thymic epithelium, does 
not perturb T cell development, indicating that DL1 is also 
dispensable for T cell lineage commitment or T cell matura-
tion in vivo (19, 30). Because DL4-expressing stromal cells 
can also induce T cell development in vitro (18, 30), it is 
conceivable that loss of DL1 function in vivo is compensated 
by DL4.
In this paper, we explore the ability of DL1 and DL4 to 
induce T cell lineage commitment and/or to infl uence T cell 
maturation in vitro and in vivo via interactions with N1 and/
or N2. Our results show that DL1 and DL4 exhibit diff erent 
Notch receptor specifi cities and that T cell fate specifi cation 
is mediated by specifi c Notch receptor–ligand interactions.
RESULTS
N2 compensates for the loss of N1 during T cell 
commitment in vitro but not in vivo
To further characterize the Notch-dependent events of T cell 
development, we examined in vivo versus in vitro T lineage 
commitment. For the in vivo analysis, we set up mixed BM 
chimeras using BM cells of conditional gene-targeted mice in 
which either the N1 or N2 genes alone or both N1 and N2 
can be inactivated simultaneously in HSCs (using the IFN-
α–responsive Mx-Cre system). Therefore, CD45.1+ WT 
lethally irradiated mice were injected with either CD45.2+ 
control (N1lox/lox; Ctrl), N1-defi cient (N1−/−), N2-defi cient 
(N2−/−), or N1N2–double-defi cient (N1N2−/−) BM pro-
genitors. Thymic T cell development was analyzed 8 wk after 
transplantation (Fig. 1 A). As previously described, inactiva-
tion of the N1 gene in BM progenitors results in a block at or 
before the earliest intrathymic precursor stage (8). Immature 
B cells develop in the thymus from incoming N1−/− BM 
progenitors, demonstrating that N1 signaling is essential for T 
lineage commitment in vivo (Fig. 1 A) (9). N2−/− BM pro-
genitors reconstituted the T cell lineage as effi  ciently as BM 
cells derived from control animals. No ectopic B cell devel-
opment was observed in the thymus of N2−/− BM chimeras. 
The only detectable hematopoietic phenotype caused by the 
inactivation of N2 was the loss of MZB cells in the spleen 
(unpublished data). In contrast, chimeric mice reconstituted 
with BM progenitors double defi cient for both N1 and N2 
recapitulated the phenotype of the N1−/− BM chimeras, sug-
gesting that T lineage commitment in vivo is exclusively 
dependent on N1 signaling.
To further characterize the N1-dependent events of T 
lineage commitment in vitro, we have made use of the OP9-
DL1 culture system (29) in which purifi ed (CD117+lin−Sca1+; 
KLS) HSCs from either Ctrl, N1−/−, N2−/−, or N1N2−/− BM 
progenitors were sorted and cultured on DL1-expressing 
OP9 stromal cells. Surprisingly, after 10 d of culture, N1−/− 
HSCs principally gave rise to DN2 (CD44+CD25+) and 
DN3 (CD44−CD25+) T cell progenitors (Fig. 1 B). No dif-
ference was observed in the ability of Ctrl or N1−/− HSCs to 
diff erentiate into immature thymocytes. To rule out the pos-
sibility that these OP9-DL1–generated DN2 and DN3 pro-
genitor cells were derived from precursor cells that had 
escaped N1 deletion, both subsets were sorted and analyzed 
by PCR for the successful inactivation of the N1 gene. The 
PCR analysis shows the expected bands characterizing the 
fl oxed and the inactivated N1 alleles of the sorted cells, re-
spectively, confi rming that the OP9-DL1–generated DN2 
and DN3 cells were indeed the progeny of N1−/− HSCs 
(Fig. 1 C).
Because N2 is expressed together with N1 on HSCs 
(Fig. 1 D), it is conceivable that N2 is able to compensate for 
the loss of N1 function during T lineage commitment when 
N1−/− HSCs are cultured on DL1-expressing OP9 cells. To 
test this hypothesis, we sorted and cultured N2−/− and 
N1N2−/− HSCs on DL1-expressing OP9 cells. After 10 d of 
OP9-DL1 culture, N2−/− HSCs gave rise to immature 
DN1–3 T cell progenitors similar to Ctrl and N1−/− HSCs 
(Fig. 1 B). In contrast, N1N2−/− HSCs do not develop into 
T cell progenitors; instead, they exhibit a developmental 
block at the putative DN1 stage characterized by the accu-
mulation of CD44+CD25− cells. This phenotype is very 
reminiscent of the defect observed in vivo in inducible N1−/− 
mice, where CD44+CD25− cells accumulated in the thymus 
and were identifi ed as B220+CD19+ B cells (Fig. 1 A) (8). 
Therefore, Ctrl, N1−/−, N2−/−, and N1N2−/− HSCs were 
assessed for their ability to develop into B cells on OP9-
DL1–expressing stromal cells. Only HSCs derived from 
N1N2−/− HSCs developed into B cells after 18 d of culture, 
whereas Ctrl, N1−/−, or N2−/− cells did not. These data con-
fi rm the hypothesis that DL1-mediated N2 signaling can 
compensate for the loss of N1 function during T lineage com-
mitment in vitro and that the presence of either N1 or N2 
alone is suffi  cient to block B cell development.
N2 cannot compensate for the loss of N1 function 
during T cell maturation
Notch signaling is not only essential for T lineage commit-
ment but is also continuously required for the successful dif-
ferentiation of all DN thymocyte subsets into CD4+CD8+ 
DP cells (14). Because N2 can instruct N1−/− HSCs to adopt 
a T cell fate on OP9-DL1–expressing stromal cells, it is 
 conceivable that N2 signaling would be suffi  cient to allow 
the subsequent DN to DP transition. To this end, Ctrl and 
N1−/− HSCs were cultured for 28 d on OP9-DL1 stromal 
cells and subsequently analyzed for the development of DP 
T cells. Although Ctrl HSCs diff erentiated very effi  ciently 
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into DP T cells, >90% of the N1−/− cells appeared to be 
blocked in the DN compartment (Fig. 2 A).
These data show that N2 signaling, although suffi  cient for 
T cell commitment of BM HSCs, is not suffi  cient for T cell 
maturation. Impaired DN to DP transition has also been ob-
served in mice in which the N1 gene was inactivated in im-
mature thymocytes using the lck-Cre transgene (25). In these 
mice, N1 defi ciency leads to a partial block of αβ T cell de-
velopment at the pre-TCR checkpoint because of inhibition 
of VDJβ rearrangement. This partial block is characterized by 
a substantial decrease in the proportion of N1−/− DN3 and 
DN4 cells expressing intracellular TCRβ protein (25). To 
investigate whether the block observed in the in vitro culture 
system at the DN to DP transition might also be caused by 
ineffi  cient expression of a TCRβ chain, intracellular TCRβ 
staining was performed on WT, DN3, or DN4 thymocytes 
or on in vitro–generated DN T cell progenitors derived from 
Ctrl or N1−/− HSCs. Approximately 60% of the in vitro–
generated DN3 and DN4 T cell progenitors derived from 
Ctrl HSCs have an in-frame TCRβ rearrangement and, thus, 
stained positive for intracellular TCRβ, compared with 29% 
of DN3 and 94% of DN4 thymocytes in vivo (Fig. 2 B). 
However, only 5 and 8% of the DN3 and DN4 cells, re-
spectively, derived from N1−/− HSCs were icTCRβ+. These 
 results show that DL1-mediated N2 signaling is not suffi  cient 
to allow diff erentiation of DN immature cells into DP T cell 
progenitors in the absence of N1 because of impaired TCRβ 
rearrangement and/or expression.
N2 mediates T lineage commitment in vivo 
in the absence of N1 signaling at extrathymic sites 
after BM transplantation
Although N1 is the key receptor for T lineage commitment 
in the thymus, our in vitro data raise the possibility that, un-
der certain conditions (when encountering the DL1 ligand), 
the N2 receptor might be able to induce T lineage commit-
ment at extrathymic sites in vivo.
Recent studies by Maillard et al. (31), Lancrin et al. (32), 
and Arcangeli et al. (33) showed that early T cell develop-
ment occurs in the spleen and LNs after BM transplantation. 
This pool of splenic T cell progenitors can effi  ciently con-
tribute to donor-derived thymopoiesis by migrating from 
the spleen to the thymus (31), where they complete T cell 
maturation. The generation of these splenic T cell progen-
itors after BM transplantation is Notch signaling dependent 
(31), because it is blocked by the expression of a dominant-
negative form of the Notch coactivator mastermind-like 1 
(31). However, it is not clear whether these extrathymi cally 
derived T cell progenitors are generated in a N1- and/or 
N2-dependent manner. To address this question, we trans-
planted CD45.2+ Ctrl, N1−/−, N2−/−, and N1N2−/− BM 
cells into lethally irradiated CD45.1+ C57BL/6 recipients. 
Donor-derived lin− cells in the spleen were analyzed 12 d 
after BM transplantation by staining for Thy1.2, CD44, 
and CD25. As previously reported, Thy1.2 and CD44 
 staining identifi ed two populations within the lin− donor-
derived cells in mice receiving Ctrl BM cells (32, 33). The 
CD44+Thy1.2− population has previously been shown to 
have multilineage potential, whereas the CD44lo/−Thy1.2+ 
population is T lineage restricted (Fig. 3) (33). The Thy1.2+ 
cells appear to be heterogeneous for the expression of CD25, 
as 
50% express this marker, which normally defi nes the 
DN2 and DN3 subsets of immature thymocytes. A similar 
population of splenic Thy1.2+ T cell progenitors was iden-
tifi ed in hosts receiving Ctrl, N1−/−, and N2−/− BM. In 
contrast, no Thy1.2+ cells were observed in the lin− donor-
derived population of hosts receiving N1N2−/− BM (Fig. 3). 
These results demonstrate that splenic T cell progenitors can 
be generated in the absence of N1 after BM transplantation 
in a N2-dependent manner. Thus, either N2 or N1 signal-
ing is suffi  cient for T lineage commitment in the spleen after 
BM transplantation.
DL1 and DL4 ligands exhibit different Notch 
receptor specifi cities
The simplest hypothesis to explain the discrepancy in the 
ability of N2 to compensate for the loss of N1 during T lin-
eage commitment in vitro but not in vivo is that the N2 
Figure 2. N2 cannot compensate for the loss of N1 function 
 during T cell maturation in vitro. (A) KLS cells from Ctrl and induced N1−/− 
mice were sorted and cultured on OP-DL1 cells for 20 d. A representative 
fl ow cytometric analysis of CD4 versus CD8 of WT thymocytes, and Ctrl 
and N1−/− KLS cells cultured on OP9-DL1 are shown. (B) Indicated cells 
were electronically gated on lineage-negative DN thymocytes and ana-
lyzed for the expression of CD44 and CD25. Representative histograms 
for intracellular TCRβ (iTCRβ) expression on DN3 and DN4 thymocytes 
 derived from Ctrl and N1−/− KLS cells 20 d after culture on OP9-DL1 are 
shown. The numbers above the bars indicate the percentage ± SD of 
iTCRβ+ cells (n = 4 for WT thymocytes and in vitro culture experiments).
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gene, although being expressed on HSCs, is not expressed in 
the earliest thymocyte progenitors. To test this hypothesis, 
semiquantitative RT-PCR was performed on all DN subsets 
derived from either BM HSCs that have been cultured 
on OP9-DL1 cells or from WT thymocytes. As shown in 
Fig. 4, both N1 and N2 were expressed in all DN subsets 
(even in DN1, CD117+CD44+CD25− subsets), irrespective 
of whether they were generated in vitro or were derived from 
thymocytes in vivo. Furthermore, no noticeable diff erences 
were observed in the expression levels of both genes in the 
diff erent DN subsets (Fig. 4). Thus, the hypothesis that the 
absence of N2 expression in early thymocyte progenitors ac-
counts for the diff erential outcome of T lineage commitment 
in vivo versus in vitro is unlikely. However, an alternative 
explanation for this discrepancy is that the outcome of Notch 
signaling might be dependent on the specifi city and/or avid-
ity of certain ligand–receptor interactions. Although DL1 is 
able to interact with N1 and N2 to trigger T lineage commit-
ment in vitro, it is conceivable that other Notch ligands may 
also trigger T lineage commitment, but only upon selective 
interaction with one specifi c Notch receptor. An attractive 
alternative ligand for N1 is DL4, a close homologue of DL1, 
which has also been shown to trigger T lineage commitment 
of WT precursors in vitro when expressed on OP9 cells (30). 
To test whether DL1 and DL4 can mediate T cell develop-
ment equally effi  ciently in vitro, sorted WT BM HSCs were 
cultured on DL1- or DL4-expressing OP9 cells and analyzed 
side by side. Although the expression level of DL4 was slightly 
lower than DL1 on OP9 cells (as judged by GFP expression; 
Fig. 5 A, left), WT HSCs developed very effi  ciently into DP 
thymocytes in both cases within 30 d of culture (Fig. 5 A, 
right). To investigate whether DL1 and DL4 exhibit diff erent 
Notch receptor specifi cities, Ctrl, N2−/−, and N1−/− HSCs 
were cultured side by side on either DL1- or DL4-expressing 
OP9 cells. After 11 d of culture, Ctrl HSCs cultured on either 
DL1 or DL4 progressed to the DN2/DN3 stage, although 
the progression appeared to be slightly more rapid on OP9-
DL4–expressing cells. Whereas all three genotypes developed 
into DN1, DN2, and DN3 T cell progenitors on DL1-
 expressing OP9 cells, only Ctrl and N2−/− HSCs, but not 
N1−/− HSCs, developed into DN1, DN2, and DN3 T cell 
progenitors when cultured on OP9-DL4 cells (Fig. 5 B). 
Within the same time frame, N1−/− HSCs could only diff er-
entiate into a putative DN1 population (CD44+CD25−) on 
OP9-DL4 cells. These data indicate that N1−/− HSCs either 
exhibit a developmental block at the DN1 to DN2 transition 
or that they may have adopted a B cell fate similar to the 
phenotype observed after inducible inactivation of N1 in BM 
progenitors in vivo (Fig. 1 A) (8, 9). Therefore, the diff erent 
OP9-DL4 cultures were stained with antibodies to the pan–B 
cell markers   B220 and CD19. As shown in Fig. 5 B (right), 
B220+CD19+ B cells were only observed when N1−/− but 
not Ctrl or N2−/− BM HSCs were cultured on OP9-DL4 
cells. These results demonstrate that DL4 and DL1 are not 
equivalent in their ability to trigger T lineage commitment, 
as DL4 can only induce T lineage commitment of BM HSCs 
Figure 3. N2 is suffi cient to specify T lineage progenitors in the 
spleen after BM transplantation. CD45.2+ Ctrl, N1−/−, N2−/−, or 
N1N2−/− BM cells were injected into lethally irradiated CD45.1+ hosts. The 
spleens of host mice were analyzed 12 d after BM transplantation. Repre-
sentative fl ow cytometric analyses of donor-derived lineage-negative cells 
for the expression of CD44 and Thy1.2, and Thy1.2 and CD25, respectively, 
are shown. Data are representative of four independent experiments.
Figure 4. Expression of N1 and N2 in immature DN thymocytes. 
cDNA was prepared from sorted cells cultured on OP9-DL1 cells for 16 d 
(corresponding to the DN1–4 subsets), and WT DN1–4 thymocyte subsets. 
Transcripts of N1 and N2 were analyzed by semiquantitative RT-PCR of 
threefold dilutions of the cDNA. The cDNA input was normalized accord-
ing to the expression of the control tubulin gene.
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that express N1. Moreover, DL4-mediated N2 signaling is 
not suffi  cient for T cell commitment nor is it suffi  cient for 
the inhibition of B cell development in vitro, suggesting that 
DL4 signals specifi cally through the N1 receptor, whereas 
DL1 can signal through both N1 and N2. To investigate 
whether DL1 and DL4 exhibit diff erent binding avidities for 
N1 and/or N2, DL1- and DL4-IgG fusion proteins were 
generated (Fig. 6 A) and assessed for their ability to bind to 
Notch receptors expressed on thymocytes. As shown in Fig. 
6 B, DL4-IgG fusion proteins bind immature DN thymo-
cytes very effi  ciently. Binding of DL4-IgG is already observed 
in the DN1 subset, peaks at the DN2 subset, gradually de-
clines through the DN3, DN4, and immature SP (ISP) sub-
sets, and is virtually absent in more mature DP and CD4 
and CD8 SP thymocytes (Fig. 6 C). Surprisingly, DL1-IgG 
fusion proteins did not stain thymocytes above background 
levels of the IgG isotype control (unpublished data), with 
the exception of the DN1 and DN2 subsets, which stained 
weakly above background. These results demonstrate that 
the DL4 fusion protein has a considerably higher binding 
avidity to Notch receptors present on immature thymocytes 
compared with DL1.
To investigate whether diff erences in the binding avidity 
of DL1- and DL4-IgG fusion proteins translate into diff eren-
tial Notch target gene induction, immature DN thymocytes 
were cultured on either DL1- or DL4-IgG–coated plastic 
dishes or on DL1- or DL4-expressing OP9 stromal cells. Ex-
pression of the Notch target genes Deltex1 and Hes1 was sub-
sequently analyzed by semiquantitative RT-PCR. Similar to 
the hierarchy observed in binding assays, induction of Deltex1 
gene expression was stronger when Notch signaling was trig-
gered by DL4 compared with DL1. However, diff erences in 
Hes1 gene expression were less pronounced or, as in the OP9 
culture system, not observed (Fig. 6 D). These results  indicate 
that diff erential Notch–Delta binding avidity correlates in 
some cases with diff erences at the level of gene expression. 
However, this correlation appears to be target gene  dependent, 
suggesting that diff erent target genes respond to diff erent 
threshold levels of Notch signaling.
Because the binding assays were performed with WT 
thymocytes, we were unable to distinguish binding of DL4-
IgG to the N1 and/or N2 receptor. Our results presented in 
Fig. 5 show that DL4, in contrast to DL1, cannot induce T 
lineage commitment via N2. This result is compatible with 
two hypotheses: either DL4 cannot bind effi  ciently to N2 or, 
alternatively, DL4 can bind N2 but cannot transmit a signal 
via the N2 receptor. To distinguish between these two possi-
bilities, we examined the binding effi  ciency of DL1- and 
DL4-IgG fusion proteins to 293T cells transiently expressing 
either N1- or N2–enhanced GFP (EGFP) fusion proteins. As 
shown in Fig. 7 (B and C, top), DL4-IgG fusion proteins 
bind N1 very effi  ciently, whereas binding to the N2 receptor 
is not detectable above background. Interestingly, DL1-IgG 
fusion proteins bind N1 weakly but do not bind N2 above 
levels of the IgG isotype control.
Modulation of Notch–Delta binding avidity 
by Lunatic fringe (Lfng)
A recent report suggests that the sensitivity of Notch recep-
tors to DL ligands in thymocytes is regulated by the glycosyl-
transferase Lfng (34). Although only N1–DL4 binding can be 
detected in transiently transfected 293T cells (Fig. 7 B, top), 
it is possible that this situation refl ects the fact that 293T cells 
express very low levels of Lfng as measured by semiquantita-
tive RT-PCR (Fig. 7 A). To investigate directly whether the 
avidity of Notch–Delta binding might be dependent on Lfng 
expression, 293T cells transiently expressing either N1 or N2 
were cotransfected with an expression plasmid encoding Lfng 
and subsequently analyzed in binding assays using DL1- and 
DL4-IgG fusion proteins. Interestingly, overexpression of 
Lfng in 293T cells allows DL1 to bind effi  ciently to N1 and 
N2. Moreover, DL4-Fc can now also bind N2 (Fig. 7 B 
and C, bottom). These results directly demonstrate that the 
binding avidity of DL ligands to Notch receptors is Lfng 
 dependent, with the possible exception of the DL4–N1 inter-
action. They furthermore highlight the possibility that Notch 
signaling might be regulated in an important way at the level 
of Lfng expression.
Figure 5. Comparison of DL1- and DL4-mediated T cell develop-
ment in vitro. (A) Histograms show fl ow cytometric analyses of GFP 
expression of uninfected OP9-cells (dashed line) and DL1 (shaded histo-
gram) and DL4 (continuous line) retrovirally transduced OP9 cells. Ctrl BM 
HSCs were sorted and cultured side by side on OP9-DL1 and -DL4 cells 
and anaylzed by fl ow cytometry for the expression of CD4 and CD8 30 d 
after culture. (B) Sorted BM HSCs derived from either Ctrl, N1−/−, or 
N2−/− mice were cultured for the indicated times on either OP9-DL1 or 
-DL4 cells and subsequently analyzed by fl ow cytometry for the expres-
sion of CD44 and CD25 (electronically gated on lineage-negative cells) 
and the presence of B220+CD19+ B cells. Data are representative of four 
independent experiments.
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Enforced expression of DL4 but not DL1 induces effi cient 
T cell development in vivo
In vitro, DL4 is unable to induce T lineage commitment in 
the absence of a functional N1 receptor, suggesting that DL4 
must specifi cally interact with N1 to specify the T lineage. 
To exclude that this observation is caused by a peculiarity of 
our in vitro culture system, we investigated the ability of DL1 
and DL4 to induce T cell development in vivo in the pres-
ence and absence of N1. Previous studies demonstrated that 
retroviral overexpression of DL4 in hematopoietic cells is 
suffi  cient to promote thymus-independent T cell  development 
to the DP stage in vivo (13, 23, 24). We therefore transduced 
CD45.2+ Ctrl and N1−/− BM cells with a retrovirus express-
ing either GFP alone (MIG), or DL1 or DL4 together with 
GFP, and subsequently transplanted these cells into lethally 
irradiated CD45.1+ C57BL/6 mice. The BM transduction 
effi  ciency of MIG and MIG expressing either DL1 or DL4 
virus (based on GFP expression) was between 55 and 60% for 
both Ctrl and N1−/− BM cells (Fig. 8 A). Reconstituted hosts 
were analyzed 9 wk after transplantation for the presence of 
GFP+ donor-derived cells in PBLs. 72% of Ctrl PBLs and 
64% of N1−/− PBLs in host mice that were transplanted with 
MIG-transduced BM cells were GFP+. Comparable percent-
ages of PBLs were GFP+ in hosts receiving either DL1- or 
DL4-expressing Ctrl and N1−/− BM cells, indicating that the 
relative number of virus-expressing Ctrl and N1−/− donor 
cells was comparable even 9 wk after transplantation (Fig. 
8 B, right). Only forced expression of DL4 but not DL1 
 resulted in the effi  cient development of DP T cells (Fig. 8, 
B–D). DL4-induced DP T cells were exclusively found in 
the PBLs (13%), BM (86%), and spleen   (48%) of Ctrl but not 
of N1−/− chimeras, suggesting that enforced DL4 expression 
can only induce T cell development of N1-expressing pro-
genitors in vivo. These results confi rm our in vitro results us-
ing the DL4-expressing OP9 cells.
D I S C U S S I O N 
The data presented in this study provide compelling evidence 
for a hierarchy of Notch–Delta interactions promoting T cell 
lineage commitment and maturation. Using the well-char-
acterized OP9 stromal cell culture system, we unexpect-
edly found that DL1 can trigger T cell lineage commitment 
Figure 6. Binding of purifi ed DL1- and DL4-IgG fusion proteins to 
thymocytes. (A) DL1- (lanes 1 and 3) and DL4-IgG fusion proteins (lanes 
2 and 4) before (lanes 1 and 2) and after (lanes 3 and 4) purifi cation over 
a protein A column were stained with Coommassie blue (left). A Western 
blot analysis of DL1- (lane 5) and DL4-IgG (lane 6) fusion proteins using 
an anti–human IgG–horseradish peroxidase–conjugated antibody is also 
shown (right). (B) The purifi ed DL1- and DL4-IgG fusion proteins were 
used to stain immature WT thymocytes. Thymocytes were stained with 
lineage cocktail and anti-CD117, -CD44, and -CD25 antibodies together 
with DL1- or DL4-IgG fusion proteins. Representative histograms 
show the staining of DL1- (gray line) and DL4-IgG (bold line) fusion 
proteins or IgG isotype control (continuous line) gated on the DN1 
(CD117+CD44+CD25−), DN2 (CD117+CD44+CD25+), DN3 (CD44−CD25+), 
and DN4 (CD44−CD25−) thymocyte subpopulations. (C) Representative 
histograms showing staining of DL1- (gray line) and DL4-IgG (bold line) 
fusion proteins gated on ISP (CD8+TCRβ−), DP (CD4+CD8+), CD4SP 
(CD4+TCRβ+), and CD8SP (CD8+TCRβ+) thymocytes. In the more mature 
thymocyte subsets (ISP, DP, and SP), DL1-IgG staining was indistinguish-
able from the IgG isotype control, which is therefore not shown in C. Data 
are representative of four independent experiments, and numbers within 
the histograms indicate means ± SD of the mean fl uorescence intensity 
for DL4. (D) Semiquantitative RT-PCR for the Notch target genes Deltex1 
and Hes1. cDNA was prepared from DN thymocytes, either cultured for 
20 h on IgG-, (DL1-IgG) DL1-Fc–, and DL4-Fc–coated plastic dishes or 
on OP9-DL1 or -DL4 cells. Transcripts of Deltex1 and Hes1 were analyzed 
by semiquantitative RT-PCR of threefold dilutions of the cDNA. The 
cDNA input was normalized according to the expression of the control 
HPRT gene.
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(to the DN CD25+ stage) via either N1 or N2 receptors 
expressed on BM precursors. In contrast, DL4 could only in-
duce T cell lineage commitment via N1. Concomitant with 
T cell lineage commitment, inhibition of B cell development 
was observed for N1–DL1, N1–DL4, and N2–DL1 receptor–
ligand pairs but not for N2–DL4. Collectively, our data dem-
onstrate novel aspects of both the specifi city and redundancy 
of Notch receptor–ligand interactions in the induction of 
T cell lineage commitment on OP9 stromal cells. Further-
more, they highlight the fact that N2 is unable to promote 
thymic T cell lineage commitment in vivo despite its ability 
to induce T cell commitment in vitro via DL1. This unex-
pected ability of N2 to substitute for N1 in the promotion 
of T cell lineage commitment was also observed in vivo in a 
short-term BM transplantation model, originally derived to 
quantitate pluripotential stem cells (35). In this system, spleen 
colonies in lethally irradiated recipients derived from single 
BM stem cells contain multiple hematopoietic lineages, in-
cluding committed T cell precursors expressing Thy-1 and 
CD25 (32, 33). Development of these extrathymic T cell 
precursors was recently shown to depend upon Notch sig-
naling, because it is inhibited by a dominant-negative form 
of the Notch coactivator mastermind-like 1 (31). Our data 
using conditional Notch knockout BM precursors clearly 
demonstrate that expression of either N1 or N2 is suffi  cient 
to promote T cell lineage commitment in the spleen after 
transplantation. The relevant Notch ligands responsible for 
T cell commitment in this system have not been identifi ed. 
Nevertheless, it is clear that DL1 is expressed on both B cells 
and DCs in the spleen (30), and DL1 is the nonredundant 
ligand responsible for N2-mediated MZB cell fate specifi ca-
tion in that organ (30). By analogy with the OP9 system, 
it is thus tempting to speculate that N2–DL1 interactions 
 account for the ability of N2 to substitute for N1 in promot-
ing extrathymic T cell lineage commitment after short-term 
BM transplantation.
Notch–Delta interactions are not only required for T cell 
lineage commitment but also for further maturation of DN 
CD25+ immature thymocytes to the DP stage both in vivo 
(25) and in vitro (14). A critical aspect of this maturation 
process is productive VDJ rearrangement of the TCRβ lo-
cus, leading to expression of a TCRβ protein and functional 
pre-TCR. In the OP9 system, it is known that both DL1 and 
DL4 can promote TCRβ rearrangement and progression to the 
DP stage when WT BM precursors are plated (18). However, 
DL1 was unable to promote the further maturation of DN 
CD25+ precursors that had developed via N2 (i.e., in the 
absence of N1). Furthermore, this defect in the generation 
of DP thymocytes was accompanied by a failure to express 
TCRβ protein in DN CD25+ cells. Collectively, these data 
indicate that N2–DL1 interactions, though suffi  cient to pro-
mote T cell lineage commitment in vitro, are unable to in-
duce subsequent T cell maturation. Thus, it is possible that 
N2–DL1 interactions in the OP9 system are of lower avid-
ity than N1–DL1 and, especially, N1–DL4 interactions, as 
further suggested by  direct binding assays of DL1 and DL4 
fusion proteins on N1- or N2-transfected 293T cells. Never-
theless, N2–DL1 interactions are readily detected in the pres-
ence of high levels of Lfng in transfected 293T cells, raising 
the possibility that the failure of N2–DL1 to induce T cell 
maturation in vitro could be explained by limiting concen-
trations of Lfng in thymic progenitors. Alternatively, N2 may 
signal less effi  ciently than N1 because of its weaker transacti-
vation domain (4).
An even more stringent requirement for Notch–Delta 
 interactions in T cell maturation was observed in an in vivo 
model where DL1 and DL4 were retrovirally transduced in 
WT and N1−/− BM precursors that were subsequently used 
to reconstitute lethally irradiated hosts. In agreement with 
several other reports (13, 23, 24), large numbers of DP cells 
developed after 9 wk in the BM, spleen, and PBLs of 
mice reconstituted with DL4-expressing WT BM  precursors. 
In contrast, DL1-expressing WT BM precursors did not 
Figure 7. Binding of DL1- and DL4-IgG fusion proteins to N1 and N2. 
(A) Semiquantitative RT-PCR for the Lfng gene. cDNAs were prepared from 
DN thymocytes and 293T cells. Transcripts were analyzed by semi-
quantitative RT-PCR of fi vefold dilutions of the cDNA. The cDNA input 
was normalized according to the expression of the control HPRT gene. 
293T cells were transiently transfected with N1- (B) or N2-EGFP (C) 
 together with or without Lfng expression vectors and stained 48 h after 
transfection with either human IgG1 isotype control or DL1- or DL4-IgG 
fusion proteins. Data are representative FACS profi les of four independent 
experiments. Extremely high EGFP-expressing cells were gated out as the 
fusion proteins were trapped inside the cells.
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generate detectable numbers of DP cells. Importantly, DL4-
induced generation of DP cells was totally dependent on 
N1, because it did not occur when reconstitution was 
performed with DL4-transduced N1−/− BM precursors. 
These results point to a highly specifi c N1–DL4 interaction 
as being essential for extrathymic T cell maturation to the 
DP stage in vivo when Delta expression is restricted to 
hematopoietic cells. The unique N1–DL4 specifi city in 
this system could be related to the fact that the N1–DL4 
 interaction is less dependent on Lfng than other Notch–
Delta interactions. According to this scenario, putative low 
levels of Lfng in HSCs could restrict their ability to undergo 
T cell maturation in the BM unless they encounter DL4 
on hematopoietic cells. This stringent requirement may be 
overcome in the OP9-DL1 system, where high levels of 
 expression of DL1 and/or other co-stimulatory properties of 
OP9 stromal cells may compensate for the putatively weaker 
N1–DL1 interaction.
The hierarchal nature of Notch–Delta interactions in im-
mature thymocytes raises the important issue of whether high 
avidity Notch–Delta binding correlates with Notch signal-
ing. In this respect, analysis of Notch target genes in DN thy-
mocytes stimulated by DL1 or DL4 (expressed on OP9 cells 
or immobilized on plastic) revealed a considerably  better in-
duction of Deltex1 by DL4, consistent with the hierarchy of 
ligand binding. However, induction of Hes1 in DN thymo-
cytes by DL1 and DL4 was comparable. Collectively, these 
data favor a scenario in which diff erences in Notch–Delta 
binding avidity translate into diff erences in some Notch sig-
naling outcomes but not in others, presumably because acti-
vation of downstream Notch signaling pathways is hierarchal 
in nature. According to this model, the ability of N1–DL1 
interactions to drive T cell lineage commitment and matura-
tion on OP9 cells in vitro would refl ect a low-threshold 
Notch signaling requirement.
Finally, it is worth noting that the hierarchy of Notch–
Delta interactions described in this study has potential impli-
cations for T cell lineage commitment and maturation under 
physiological conditions in the thymus. In this context, 
it is of particular interest that N2 is capable of promoting 
T cell commitment via interaction with DL1 (but not DL4) 
both on OP9 stromal cells and during extrathymic T cell 
development in the spleen. This raises the obvious question 
of why N2 cannot compensate for N1 during T cell lin-
eage commitment in the thymus. Because N2 is expressed on 
HSCs and early intrathymic T cell precursors, one possible 
Figure 8. Comparative in vivo analysis of DL1 and DL4 for their 
ability to promote ectopic T cell development. (A) Bar diagrams show 
percentages of GFP+ Ctrl and N1−/− BM cells after transduction with the 
control virus (MIG) and virus expressing DL1 and DL4. (B) Histograms 
show the percentage of GFP+ cells within total PBLs in host mice 9 wk 
after BM transplantation. Flow cytometric analysis for the presence of 
CD4- and CD8-expressing T cells was performed on PBLs (B) and BM and 
spleen (C) of host animals that were transplanted with WT and N1−/− 
BM cells expressing the indicated ligands.
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explanation for the inability of N2 to support T cell com-
mitment would be that DL1 is not present or available in 
the thymus. Because N2 cannot promote T cell  commitment 
via DL4 even in the sensitive OP9 stromal system, it is 
unlikely that N2–DL4 interactions would induce T cell 
 development in vivo. This scenario would therefore imply 
that DL4 is in fact the physiological ligand for N1 during 
intrathymic T cell development and, more generally, that 
 tissue-specifi c compartmentalization of Delta family members 
is a mechanism to assure Notch receptor–ligand specifi city in 
cell fate determination.
A second aspect of hierarchal Notch–Delta interac-
tions that is relevant to the identifi cation of the physiologi-
cal ligand of N1 during thymus development is the unique 
ability of DL4 to specifi cally bind to immature thymocytes 
with apparent high avidity. Conditional inactivation of N1 
in BM precursors (8, 9) and at early stages of intrathymic 
development (25) has clearly demonstrated that signaling 
via N1 is required in immature DN thymocytes until they 
have completed VDJβ rearrangement at the CD25+ DN3 
stage, whereas later N1 inactivation (from the DN4 stage 
onwards) has no impact on subsequent thymus development 
(36). Interestingly, binding of DL4 by N1 in thymus subsets 
closely parallels this functional requirement, because DL4 
binding is high from the DN1 to DN3 stages and declines 
in DN4 to become undetectable in subsequent DP and SP 
stages. This result is again consistent with the hypothesis 
that DL4 is the physiological N1 ligand responsible for both 
T cell lineage commitment and subsequent thymic matu-
ration. Moreover, the strict correlation between N1–DL4 
binding and N1 function during this process further suggests 
that N1 signaling on developing thymocytes is regulated 
at the level of ligand binding. Because N1–DL4 binding 
 activity appears to be relatively independent of Lfng (at least 
in transfected 293T cells), it could be speculated that N1 
function during thymic maturation is largely controlled at 
the level of N1 expression.
Expression studies of DL1 and DL4 in the thymus, though 
not defi nitive, also favor the hypothesis that DL4 may be the 
physiological N1 ligand for T-lineage commitment and mat-
uration. Thus, semiquantative PCR analysis indicates that 
DL4 is more strongly expressed than DL1 in the embryonic 
(18) as well as adult (15, 30) thymus epithelium. More con-
vincingly, in situ hybridization studies, as well as lacZ gene–
targeted (knock-in) reporter mice demonstrated clearly that 
DL4 is expressed at relatively high levels in situ in both em-
bryonic and adult thymus (13, 16, 17), whereas DL1 expres-
sion is barely or not detectable (unpublished data) (16, 37). At 
the protein level, one group has reported broad expression of 
DL1 in the adult thymus (14); however, the specifi city of the 
polyclonal anti-DL1 antibody used in that study has been 
challenged (15). Collectively, these data are consistent with 
the possibility that DL4 rather than DL1 is the physiological 
thymic ligand for N1. Indeed, conditional inactivation of 
DL1 in the thymic epithelium does not impair T cell devel-
opment (30). Nevertheless, it remains possible that DL1 and 
DL4 function redundantly in N1-mediated T cell lineage 
commitment. Conditional gene targeting of DL4 will be 
 required to defi nitively resolve this important issue.
MATERIALS AND METHODS
Mice and induction of the Cre-mediated inativation of the fl oxed 
N1 and N2 genes. Experiments were performed according to Swiss guide-
lines and authorized by the veterinary authorities of the Canton de Vaud 
(authorization nos. 1099.2 and 1099.3). CD45.1+ C57BL/6 mice were pur-
chased from the Jackson Laboratory. N1lox/lox&Mx-Cre mice were generated as 
previously described (8). For N2lox/lox mice, the generation of the N2 target-
ing vector was based on a genomic DNA fragment including the exons b to h 
and the 5′ part of exon i (according to the nomenclature previously  described 
[38]) from the mouse N2 locus. Exons d and e (coding for the C-terminal 
part of the RAM23 domain and nuclear localization sequence) were fl anked 
by loxP sites. Cre recombinase–mediated N2 inactivation results in the 
 expression of a truncated N2 protein, lacking the intracellular part. The gen-
erated mice carrying the loxP-targeted exons d and e are referred to here as 
the fl oxed N2 allele (N2lox).
Generation of the N2 targeting vector and targeting of embryonic 
stem (ES) cells. Construction of the targeting vector based on the geno-
mic N2 phage DNA clone 1NT2-2 (provided by Y. Hamada, National 
 Institute of Basic Biology, Okazaki, Japan) containing the distal exons a to i 
(exon c turned out to consist of two small neighboring exons, designated 
by us as c1 and c2). A 9.5-kb SphI fragment from 1NT2-2 encompassing 
N2 exons b to h and the 5′ part from exon i was subcloned into the 
backbone vector pHEBOpl-mod, which was previously created from the 
plasmid pHEBO (39) by replacement of a 630-bp ClaI/SalI fragment with a 
polylinker sequence and subsequent deletion of a 2.9-kb MluI fragment. 
Within the genomic N2 SphI fragment, insertions were made at three posi-
tions: (a) at the BsrBI site between exons c2 and d, a loxP-fl anked neomycin 
resistance gene cassette (NeoR) from pEasyFlox (provided by Marat Alim-
zhanov, Harvard Medical School, Boston, MA; unpublished data; reference 40) 
containing an additional SacI/SstI recognition site between the 5′ loxP 
site and NeoR was inserted; (b) at the XhoI site between exons e and f, a 
loxP sequence with a SacI/SstI recognition site at its 3′ end was inserted; 
and (c) a thymidine-kinase expression cassette (XhoI/PvuI fragment from 
pEasyFlox) was cloned into the SphI site at the 3′ end of the genomic N2 
sequence (within exon i).
The fi nal targeting vector pU1496-21 was sequenced, linearized by 
NotI, and electroporated into BALB/c-derived ES cells. G418-resistant and 
ganciclovir-sensitive colonies were screened for homologous recombination 
by Southern blot analysis. The cellular DNA was digested with SstI (a SacI 
isoschizomer) and hybridized with a specifi c N2 probe (a 490-bp SacI/SphI 
fragment located just upstream of the 5′ end of the genomic N2 sequence in 
the targeting vector). The WT N2 and the targeted N2 alleles were identi-
fi ed as 7.2- and 2.9-kb fragments, respectively. Clones with homologous 
 recombination were further confi rmed by hybridization with an internal probe 
(NeoR) and a 3′ external probe (271-bp SphI/SacI fragment from exon i). 
Of 768 analyzed ES cell clones, four exhibited correct recombination with 
the targeting vector.
In one correctly targeted ES cell clone (1G10), the loxP-fl anked NeoR 
was deleted in vitro by transfection with the cre expression vector pIC-cre 
(41). The resulting single-cell clones were screened for correct deletion of 
the NeoR cassette by Southern blotting, as decribed in the previous para-
graph. The fl oxed N2 allele could be identifi ed as a 5.7-kb fragment. Two 
of the ES cell clones with NeoR deletions were reconfi rmed by sequencing 
and injected into C57BL/6 blastocysts, which were then transferred into 
foster mothers to obtain chimeric mice. Floxed N2 gene –targeted mice were 
provided by K. Rajewsky (Harvard Medical School, Boston, MA).
Activation of the Cre recombinase was performed as previously de-
scribed (8, 9). In brief, Ctrl, (N1lox/lox), N1lox/lox&Mc-Cre, N2lox/lox&Mx-Cre, and 
N1/N2lox/lox&Mx-Cre mice received fi ve i.p. injections of 250 μg polyI-polyC 
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(pIpC; Sigma-Aldrich) at 2-d intervals. Competitive mixed BM chimeras 
were set up as previously described (9). In brief, lethally irradiated mice (950 
rads 24 h before transfer) that had been treated i.p. 48 h before BM trans-
plantation with 100 μg anti-NK1.1 monoclonal antibodies were reconsti-
tuted with a 1:2 mixture (5 × 106:10 × 106) of CD45.1+ WT and Ctrl, 
N1lox/lox&Mc-Cre, N2lox/lox&Mx-Cre, or N1/N2lox/lox&Mx-Cre BM for mixed chimeras. 
Mice were maintained on antibiotics (Bactrim) containing water, and re-
constitution of BM and lymphoid organs by donor-derived cells was  analyzed 
8 wk later.
Flow cytometry and cell sorting. The following monoclonal anti-
body conjugates were purchased from eBioscience: CD117 (2B8)-PE and 
-PE-Cy5.5; Sca-1 (D7)-PE and -APC; CD19 (MB-19.1)-PE and (6D5)-
PE-Cy5.5; B220 (RA3.6B2)-PE-Cy5.5 and –Alexa Fluor 647; CD44 
(IM781)-PE-Cy5.5; CD25 (PC61)-APC; CD4 (L3T4)-PE-Cy5.5; CD45.2 
(104)-PE-Cy5.5; TCRβ (H57)-PE and -APC; CD161 (PK136)-FITC; 
CD90.1 (HIS15)-PE; and CD90.2 (30H12)-PE. TCRγδ (GL3)-PE and 
TCRβ (H57)-biotin were purchased from BD Biosciences. CD25 (PC61)-
PE was purchased from Caltag. CD19 (ID3)–Alexa Fluor 647; B220 
(RA3.6B2)–Alexa Fluor 647; CD4 (GK1.5)-FITC and -PE; CD8α (53.6.7)-
FITC and –Alexa Fluor 647; CD45.1 (A20)–Alexa Fluor 647; CD45.2 
(104)–Alexa Fluor 647; TCRβ (H57)-FITC; TCRγδ (GL3)-FITC; Gr1 
(RB6.8C5)-FITC; Ter119-FITC; CD11b (M1/70)-FITC, -PE, and –Alexa 
Fluor 647; and CD3 (17A2)-FITC were purifi ed from hybridoma super-
natants and conjugated in our laboratory according to standard protocols. 
Alexa Fluor 647 conjugates were prepared using the appropriate Alexa Fluor 
protein labeling kits (Invitrogen). APC and PE conjugates were prepared 
using kits purchased from Prozyme. Intracellular staining for TCRβ was 
performed as previously described (42). Single-cell suspensions were stained 
with the respective antibodies and analyzed using a FACSCalibur or FAC-
Scanto fl ow cytometer (Becton Dickinson). The cells were sorted with a 
FACSVantage or a FACSAria fl ow cytometer (Becton Dickinson). Dead 
cells and debris were eliminated by appropriate gating on forward and side 
scatter. The data were analyzed using either CellQuest Pro (BD Biosciences) 
or FlowJo (TreeStar, Inc.) software.
OP9 cell co-cultures. OP9 stromal cells engineered to express GFP and 
the mouse DL1 gene (OP9-DL1 cells, provided by J.C. Zuniga-Pfl ücker, 
University of Toronto, Toronto, Canada) or GFP and the mouse DL4 gene 
(OP9-DL4 cells provided by A. Cumano, Institut Pasteur, Paris, France) 
were cultured in αMEM supplemented with 20% FBS (Sigma-Aldrich). 
HSCs were isolated from adult mouse BM and sorted as lin−CD117hiSca-1hi. 
HSCs were seeded at 4 × 103 cells/well onto 80% confl uent monolayers of 
OP9 cells (24-well plates) in DMEM with 10% FBS. Every third day, 1 ml 
of the culture supernatant was exchanged with fresh medium. Co-cultures 
were harvested by pipetting at the time points indicated in the fi gures, and 
contaminating OP9 cells were eliminated by fi ltering the lymphocytes 
through a 70-μm cell strainer (BD Biosciences) before replating or fl ow cy-
tometric analysis. All co-cultures were performed in the presence of 5 ng/ml 
rmIL-7 and rhFlt3L (PeproTech).
Semiquantitative RT-PCR. Total RNA was isolated using TRIzol reagent 
(Invitrogen), and semiquantitative PCR was performed using the Onestep 
RT-PCR kit (QIAGEN). All PCR reactions were performed using the same 
serially diluted RNA samples normalized to an α tubulin– or hypoxanthine 
guanine phosphoribosyl transferase (HPRT)–specifi c signal. Gene–specifi c 
primer sequences were as follows: N1, (forward) 5′-T G T G A C A G C C A G T G-
C A A C T C -3′ and (reverse) 5′-G C A G T G C T T C C A G A G T G C C A -3′; N2, 
(forward) 5′-A C A T C A T C A C A G A C T T G G T C -3′ and (reverse) 5′-G G C-
A G C T G C T G T C A A T A A T G -3′; tubulin, (forward) 5′-T C A C T G T G C C T-
G A A C T T A C C -3′ and (reverse) 5′-G G A A C A T A G C C G T A A A C T G C -3′; 
mouse and human HPRT, (forward) 5′-A A G G A G A T G G G A G G C C A T C-
A C -3′ and (reverse) 5′-C T T G T C T G G A A T T T C A A A T C C A A C -3′; Del-
tex1, (forward) 5′-C A C T G G C C C T G T C C A C C C A G C C T T G G C A G G -3′ 
and (reverse) 5′-G G G A A G G C G G G C A A C T C A G G C C T C A G G -3′; Hes1, 
(forward) 5′-A T C A T G G A G A A G A G G C G A A G G G -3′ and (reverse) 5′-T G A-
T C T G G G T C A T G C A G T T G G -3′; and mouse and human Lfng, (forward) 
5′-C G C G C C A C A A G G A G A T G A C G T T C -3′ and (reverse) 5′-T G G G C-
A C C T G C T G C A G G T T C T -3′. PCR products were resolved by  agarose 
gel electrophoresis and visualized by ethidium bromide staining. All PCR 
products shown correspond to the expected molecular size (Figs. 1, 4, 
6, and 7).
Purifi ed DL1- and DL4-IgG were also used to stimulate in vitro DN 
thymocytes. In brief, 24-well plates were coated with 10 μg/ml protein A 
overnight at 4°C. 10 μg/ml of purifi ed DL1- and DL4-IgG was added to the 
plates for 1 h at 4°C. Lineage-depleted DN thymocytes were subsequently 
plated on DL fusion protein–coated plates at 2 × 106 cells/well. After 20 h 
of culture, DN thymocytes were harvested to analyze gene expression by 
semiquantitative RT-PCR.
Spleen CFU (CFU-S) assay. CD45.1+ C57BL/6 mice were exposed to 
lethal whole-body irradiation (950 rads) from a 137Cs source and maintained 
on water containing antibiotics (Bactrim). The next day, total BM cells 
(12 × 104) from either Ctrl, N1−/−, N2−/−, or N1N2−/− mice were injected 
i.v. via the retroorbital sinus. After 12 d, spleens of the recipient mice were 
removed, and single-cell suspensions were prepared for FACS analysis.
In vitro stimulation of 5-FU–treated BM cells. 1 wk after the last polyI-
polyC injection, N1lox/lox and N1lox/lox&Mx-Cre mice were treated with 3 mg/20 g 
body weight of 5-fl uorouracil (Sigma-Aldrich). 5 d later, BM cells were 
harvested and, after red blood cell lysis, single-cell suspensions were prepared 
in stem cell–activating (SA) medium containing IMDM supplemented with 
10% FBS, 100 ng/ml rmSCF (R&D Systems), 50 ng/ml rmTPO (R&D 
Systems), and 50 ng/ml rmFlt-3L (R&D Systems). The cells were incubated 
overnight at 37°C in 5% CO2 before the retroviral infection.
Retrovirus production and infection procedure. Empty (MIG) or re-
combinant (DL1 and DL4) retroviruses (provided by A. Freitas, Institut Pas-
teur, Paris, France) were obtained after transfection of Bosc23 packaging 
cells using lipofectamine 2000 (Invitrogen). Retrovirus-containing super-
natants were collected 48 h after transfection. 3-cm petri dishes were coated 
with 1 ml of RetroNectin (r-fi bronectin fragment CH-296; TaKara) solu-
tion (12.5 μg/ml in PBS) for 2 h at room temperature. After removal of the 
RetroNectin, 2 ml PBS + 2% BSA was added to each dish for 30 min. After 
washing the plates with PBS, the retroviral supernatant was added to the 
coated plates for 1 h at 37°C. The prestimulated BM cells were spun down, 
resuspended in 1 ml of fresh SA medium, and added to the retroviral super-
natant. The next day, 1–3 × 106 cells were injected i.v. into lethally irradi-
ated CD45.1+ C57BL/6 mice.
To ensure similar functionality and/or expression of DL1 and DL4, the 
retroviruses were assessed before BM infection by Western blot analysis, 
as well as by infecting OP9 cells that were subsequently tested for their 
ability to induce T cell development in vitro. Based on these criteria, DL1 
and DL4 retroviruses were equivalent (Fig. S1, available at http://www.jem
.org/cgi/content/full/jem.20061442/DC1).
Expression plasmids and transfections. The mouse cDNA coding for 
the extracellular domain of either DL1 or DL4 was cloned via HindIII/
BamHI and EcoRI/SalI, respectively, into the PS 521 expression vector (43) 
to generate DL1- and DL4-IgG fusion proteins. The corresponding expres-
sion vectors were transfected into 293T cells using the calcium-phosphate 
method, and IgG fusion proteins were subsequently purifi ed over protein A 
columns according to the manufacturer’s instructions (HiTrap rProtein A 
FF; GE Healthcare). Purity of the fusion proteins was verifi ed by Coomassie 
blue staining and Western blot analysis. Full-length N1 and N2 cDNAs were 
cloned in frame into the pEGFP-N1 expression vector (CLONTECH Lab-
oratories, Inc.). The mouse cDNA coding for the Lfng was cloned via 
BamHI into pcDNA3.1− (Invitrogen). 293T cells were transiently trans-
fected with 5 μg N1- and N2-EGFP expression vectors, respectively, with 
or without the Lfng expression vector. 48 h later, the cells were indirectly 
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stained with DL1- or DL4-IgG fusion proteins (0.5 μg/106 cells). Binding 
of the fusion proteins to the Notch receptors was detected using biotinylated 
anti–human IgG antibodies.
Online supplemental material. Fig. S1 shows a functional test for DL1- 
and DL4-expressing retroviruses. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20061442/DC1.
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